Navigation Links
Actavis Extends Portfolio With Four New Products in the U.S.
Date:2/27/2008

MORRISTOWN, N.J., Feb. 27 /PRNewswire/ -- Actavis Group, the international generic pharmaceuticals company, has received approval on four new products from the U.S. Food & Drug Administration.

The four products include:

Phendimetrazine tartrate tablets, 35mg: the generic equivalent of Bontril(R) tablets by Valeant Pharmaceuticals, are indicated in the adjunct management of weight loss. Annual sales of Phendimetrazine tartrate tablets had annual sales of US$3.1 million for the 12 months ending December 2007 according to IMS Health data.

Buspirone tablets, 30mg: the generic equivalent of Bristol Myers Squibb's Buspar(R). Buspirone tablets, used in the treatment of anxiety disorders, had annual sales of US$15.4 million for the 12 months ending December 2007 according to IMS Health data.

Baclofen tablets: the generic equivalent of Lioresal(R) tablets by Novartis, will be available in 10mg and 20mg strengths. Baclofen tablets are used to relax muscles and relieve pain and discomfort associated with certain nerve disorders.

Benztropine Mesylate Tablets, 0.5mg, 1mg, 2mg: are the generic equivalent to Cogentin(R). Benztropine mesylate is an antidrykinetic, which reduces the symptoms of Parkinson's disease by improving muscle control and reducing stiffness. Annual sales of Benztropine mesylate were US$12.8 million for the 12 months ending December 2007 according to IMS Health data.

Commenting on the new approvals, Terry Fullem, Vice President of Marketing and Portfolio in the U.S. said:

"These approvals signify our commitment to provide our customers with a broad and expanding pipeline. We launched 19 products in the United States in 2007 and plan to increase that number in 2008. Actavis currently has over 70 pending applications at the FDA, including a growing list of first-to-file generic products. This momentum in our development pipeline will ensure that we continue to be on the forefront of bringing new generic pro
'/>"/>

SOURCE Actavis Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Actavis Confirms its Patent Challenge of Kings Avinza(R)
2. Actavis Launches Amlodipine Tablets in the U.S.
3. Actavis Launches Carvedilol Tablets in the U.S.
4. EMC Extends Innovation for VMware environments
5. The Centers for Medicare & Medicaid Services Extends LifeMasters Demonstration Project in Florida
6. BioMed Realty Trust Joint Venture Enters Into New $245 Million Construction Loan and Extends Term of Existing Loan Facility
7. Office of Administration Extends Retired State Employees Health Benefits Enrollment Period to March 21
8. Compuware Covisint Extends Commitment to Healthcare Industry with Acquisition of Hilgraeve, Inc.
9. A Little Regular Exercise Extends Mens Lives
10. Advanced Home Care Extends Its Use of Authentidates Inscrybe(TM) Healthcare Platform
11. OSHA Extends Comment Period for Lookback Review of Methylene Chloride Standard
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... Center have found a direct link between neighborhood ... in African American women. The study, which appears ... , is the first prospective study to examine ... of type 2 diabetes in a large, geographically ... diabetes is estimated to affect 20.6 million people ...
(Date:2/9/2010)... Texas , Feb. 9 ... and project coordinator for the University of North ... Health Science Center , was instrumental in recently identifying ... in the Patio 29 cemetery. ,, The Chilean ... lead geneticist for a process audit team of the ...
(Date:2/9/2010)... most comprehensive study to date of secondhand smoke exposure ... journal Addiction . The study, carried out by ... reveals that exposure to household secondhand smoke among children ... researchers wanted to find out if there were ways ... children in private households, and whether those levels were ...
(Date:2/9/2010)... more effective in persuading young women to use birth ... according to a new study. , Researchers found that ... teen pregnancy felt more vulnerable two weeks after watching ... using birth control. , However, those who watched a ... were unmoved, and had no change in their intentions ...
(Date:2/9/2010)... 2010) AcademyHealth today recognized research that improves patient ... Services Research (HSR) Impact Award. The WHO Surgical ... ensure adherence to basic safety standards of care. ... that clearly translated into policy and, ultimately, made ... W. David Helms, Ph.D. "The WHO Surgical Safety ...
Breaking Medicine News(10 mins):Health News:Neighborhood socioeconomic status and diabetes 2Health News:UNT Health Science Center's Roby Helps Identify Bodies of Chile's Patio 29 2Health News:UNT Health Science Center's Roby Helps Identify Bodies of Chile's Patio 29 3Health News:Exposure to secondhand smoke among children in England has declined since 1996 2Health News:TV drama can be more persuasive than news program, study finds 2Health News:TV drama can be more persuasive than news program, study finds 3Health News:TV drama can be more persuasive than news program, study finds 4Health News:2010 HSR Impact Award recognizes surgical safety research 2
... Island College Hospital in Brooklyn is in news for the ... Long Island College Hospital are investigating the circumstances that led ... the wrong side of a patient’s brain to remove a ... as stable after a corrective surgery was conducted on the ...
... After waging wars over many drug formulations the pharma majors ... set in motion by the dramatic announcement of Indian firm ... less than a U.S. dollar a day. Not to be ... own production of anti retroviral drugs for AIDS treatment. , ...
... 7 months was the first recipient of a bloodless ... America. The seven month old, Aiden Michael Rush, whose ... to receive transfusions. The boy received 20% of his ... the children’s hospital in Los Angeles. , To avoid ...
... overcome a major obstacle to treating brain ailments such ... studies in rats, researchers from the Stroke Lab and ... “a direct path from the nose to the brain” ... from foreign substances, including drugs. Senior investigator Dr. ...
... The gay capital? of the world, San Francisco is now reeling ... In the past one-year the rate of infection has actually doubled ... men, who are also intra venous drug users, the rates are ... ,Hold your breath! The successful control of spread of HIV ...
... is a gift, exclusive to the blessed. The less ... problems such as early morning headaches or serious daytime ... its mild or moderate form is commonly experienced. Sleep ... breathing during sleep. Most individuals may have less severe ...
Other Medicine News:Health News:Nasal Spray Could Take Drugs Direct to Brain. 2
(Date:2/8/2010)... LOUIS , Feb. 8 Cost ... Healthcare Products (Nasdaq: AHPI ) narrowly back into ... ,, Sales for the quarter ended December 31, ... $12.5 million during the same quarter last year ... However, Allied,s costs of sales were reduced even more ...
(Date:2/8/2010)... EAST BRUNSWICK, N.J. , Feb. 8 /PRNewswire-FirstCall/ ... today that the company will release financial results for ... of the market on Thursday, February 25, 2010 ... David Gionco, Group Vice President and Chief Financial Officer, ... 10:00 a.m. Eastern Time on February ...
(Date:2/8/2010)... Feb. 8 Hanger Orthopedic Group, Inc. (NYSE: ... report its results of operations for the year ended ... . ,, The Company plans to issue a press release ... 2009 on Wednesday, February 10, 2010 , after ... to begin at 9:00 a.m., EST , on ...
Breaking Medicine Technology:Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 2Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 3Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 4Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 5Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 6Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010 2Hanger Orthopedic Group, Inc. Announces 2009 Year-End Earnings Release Conference Call 2New type of genetic change identified in inherited cancer 58828 1New type of genetic change identified in inherited cancer 58828 2New type of genetic change identified in inherited cancer 58828 3Study finds 231 new genes associated with head and neck cancer 10252 1Study finds 231 new genes associated with head and neck cancer 10252 21 Million Preemie Babies Die Each Year 3A Report 58826 11 Million Preemie Babies Die Each Year 3A Report 58826 21 Million Preemie Babies Die Each Year 3A Report 58826 3
... announced today the 28 recipients of the 2009 Seed Grant Research Program. ... physician residents and fellows to conduct basic science, applied or clinical research ... four categories: , , , ... HIV/AIDS , Leukemia , ...
... 6 B-R-A-H-M-S,Aktiengesellschaft today announced it has submitted ... (FDA) to market its patented B-R-A-H-M-S,MR-proANP Kryptor Test. ... (ANP) is predominantly produced in the atrium,of the ... in the,circulation. ANP is involved in natriuresis, diuresis, ...
Other Medicine Technology:AMA Foundation Announces Seed Grant Research Recipients 2AMA Foundation Announces Seed Grant Research Recipients 3FDA Submission of B-R-A-H-M-S MR-proANP Kryptor 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: